Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion

Targeted therapies based on EGFR mutations or on the ALK fusion oncogene have become the standard treatment for certain patients with lung adenocarcinoma (LUAD). However, most LUAD patients have no EGFR mutation or ALK fusion, and their oncogenetic alterations remain to be characterized. Here we con...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yanzhuo, Li, Bingjin, Zhang, Guangxin, He, Yuxiao, Bae, Jeeyoo Hope, Hu, Fengping, Cui, Ranji, Liu, Runhua, Wang, Zhou, Wang, Lizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868177/
https://www.ncbi.nlm.nih.gov/pubmed/29581789
http://dx.doi.org/10.7150/jca.23909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868177/
https://www.ncbi.nlm.nih.gov/pubmed/29581789
http://dx.doi.org/10.7150/jca.23909

Ejemplares similares